Objectives. To evaluate whether short (5 to 8.5 mm) dental implants could be a suitable alternative to longer (at least 11.5 mm long) implants for supporting dental prostheses placed in atrophic fully edentulous maxillae augmented with autogenous bone.
Materials and methods. Twenty-eight patients with fully edentulous atrophic maxillae having 5 to 9 mm of residual crestal bone height at least 5 mm thick, as measured on CT scans, were randomised into two groups, either to receive four to eight short (5 to 8.5 mm) implants (15 patients) or autogenous bone from the iliac crest to allow the placement of at least 11.5 mm-long implants (13 patients). Both bone blocks and windows at lifted maxillary sinuses were covered with rigid resorbable barriers. Grafts were left to heal for 4 months before placing implants, which were submerged. After 4 months, provisional reinforced acrylic prostheses or bar-retained overdentures were delivered. Provisional prostheses were replaced after 4 months by definitive screw-retained metal-resin cross-arch restorations. Outcome measures were: augmentation, prosthesis or implant failures, any complications, peri-implant marginal bone level changes, and patient satisfaction. Patients were followed-up until 5 years after loading.
Results. All patients could be rehabilitated with implant-supported prostheses, but four patients dropped-out from the augmentation group and three from the short implant group. One bilateral sinus lift procedure failed due to infection, though short implants could be placed. Four implants failed in four patients from the augmentation group versus three short implants in three patients (Fisher’s exact test P = 0.6500; difference in proportions = -0.17; 95% CI -0.51 to 0.21). No prosthesis failed. Significantly more complications occurred in augmented patients: 12 complications occurred in nine augmented patients versus one complication in the short implant group (Fisher’s exact test P = 0.0003; difference in proportions = -0.82; 95% CI -0.97, -0.41). Periapical radiographs of only four patients were readable, so no bone level could be measured at 5 years after loading. With the exception of three patients from the augmentation group, who were only partially satisfied with function, all remaining patients were fully satisfied with the treatment (P = 0.0957); all would have the treatment again.
Conclusion. This study showed that in patients with fully edentulous atrophic maxillae, short implants can be a preferable alternative to longer implants placed in bone augmented with autogenous bone, the treatment being less invasive, cheaper, faster and associated with fewer complications.
Authors: Carlo Barausse, Tiziano Maranesi, Roberto Pistilli, Pietro Felice
To evaluate the current state of the art in the surgical management of the fixed rehabilitations in the vertical atrophies of the jaws. Guide- lines and clinical indications will be given, with a...
Implantology 10 November 2020
Authors: G. Cannizzaro, P. Felice, D. R. Ippolito, M. Lazzarini, E. Velasco-Ortega, M. Esposito
OBJECTIVES: To compare 10- to 16-mm-long implants inserted into maxillary sinuses augmented with a lateral approach versus 8-mm-long implants placed in crestally augmented sinuses, both loaded early...
Long-term studies have shown that there is no significant difference between the success rates of implants placed in natural alveolar bone and those placed in...
Periodontology 27 June 2025
Bone augmentation procedures to enable dental implant placement are frequently performed in practice.
News 07 August 2023
BioHorizons Camlog to present new perspectives on guided bone augmentation at EAO Congress in Berlin
At the BioHorizons Camlog stand H09, participants can discover the company's portfolio of innovative and holistic regenerative solutions in biomaterials and...
Products 18 November 2026
News 18 November 2026
Angelalign Technology Appoints Marco Gadola as Senior Advisor
(6699.HK) (“Angel”), a global clear aligner leader, recently announced that Marco Gadola has joined the company as Senior Advisor.
News 18 November 2026
(“Align”) (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exo
Editorials 18 November 2026
The Pediatric Dentistry Alumni Association supports the IU Pediatric Dentistry Department and students in a variety of ways.
Orthodontics 18 November 2026
This peer-reviewed orthodontics article summarizes clinical evidence from Dental press journal of orthodontics (2024). It focuses on findings that may help dental professionals evaluate treatment...